2012 annual financial data
Amphastar Pharmaceuticals 2012 Operating cash flow margin
Direct answer
Operating cash flow margin was -0.81%.
Operating income was 25,397,000 USD and net income was 18,094,000 USD.
Operating cash flow was -1,650,000 USD.
Get free Amphastar Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 204,323,000 USD
- Operating income
- 25,397,000 USD
- Net income
- 18,094,000 USD
- Operating cash flow
- -1,650,000 USD